PubRank

R Marre

Author PubWeight™ 119.17‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Deletions of chromosomal regions coding for fimbriae and hemolysins occur in vitro and in vivo in various extraintestinal Escherichia coli isolates. Microb Pathog 1990 3.18
2 Aggregation substance of Enterococcus faecalis mediates adhesion to cultured renal tubular cells. Infect Immun 1992 2.69
3 Detection of legionellae in hospital water samples by quantitative real-time LightCycler PCR. Appl Environ Microbiol 2001 2.43
4 Ochrobactrum anthropi bacteremia: report of four cases and short review. Infection 1994 2.13
5 Outcome of community-acquired pneumonia: influence of age, residence status and antimicrobial treatment. Eur Respir J 2008 1.97
6 Pulsed field electrophoresis of genomic restriction fragments for the detection of nosocomial Legionella pneumophila in hospital water supplies. J Clin Microbiol 1991 1.89
7 Fluoroquinolone resistance of Escherichia coli at a cancer center: epidemiologic evolution and effects of discontinuing prophylactic fluoroquinolone use in neutropenic patients with leukemia. Eur J Clin Microbiol Infect Dis 2005 1.83
8 CRB-65 predicts death from community-acquired pneumonia. J Intern Med 2006 1.61
9 Infection of Acanthamoeba castellanii by Chlamydia pneumoniae. Appl Environ Microbiol 1997 1.55
10 Community-acquired pneumonia through Enterobacteriaceae and Pseudomonas aeruginosa: Diagnosis, incidence and predictors. Eur Respir J 2009 1.54
11 Aggregation substance promotes adherence, phagocytosis, and intracellular survival of Enterococcus faecalis within human macrophages and suppresses respiratory burst. Infect Immun 2000 1.53
12 Emergence of fluoroquinolone-resistant Escherichia coli at a cancer center. Antimicrob Agents Chemother 1994 1.49
13 gyrA mutations in high-level fluoroquinolone-resistant clinical isolates of Escherichia coli. J Antimicrob Chemother 1996 1.48
14 Staphylococcus saprophyticus urease: characterization and contribution to uropathogenicity in unobstructed urinary tract infection of rats. Infect Immun 1989 1.47
15 Cloning and genetic characterization of the flagellum subunit gene (flaA) of Legionella pneumophila serogroup 1. Infect Immun 1995 1.47
16 [New therapeutic strategies for community acquired pneumonia]. Internist (Berl) 2005 1.43
17 Contribution of cloned virulence factors from uropathogenic Escherichia coli strains to nephropathogenicity in an experimental rat pyelonephritis model. Infect Immun 1986 1.43
18 Cloning and expression of Staphylococcus saprophyticus urease gene sequences in Staphylococcus carnosus and contribution of the enzyme to virulence. Infect Immun 1989 1.43
19 Genome analysis of Legionella ssp. by orthogonal field alternation gel electrophoresis (OFAGE). FEMS Microbiol Lett 1990 1.39
20 The lipopolysaccharide of Legionella pneumophila serogroup 1 (strain Philadelphia 1): chemical structure and biological significance. Prog Clin Biol Res 1995 1.37
21 Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes. Eur Respir J 2007 1.34
22 Prevalence of antibiotic resistance in Escherichia coli: overview of geographical, temporal, and methodological variations. Eur J Clin Microbiol Infect Dis 2007 1.31
23 Overexpresssion of a Legionella pneumophila homologue of the E. coli regulator csrA affects cell size, flagellation, and pigmentation. Int J Med Microbiol 2001 1.29
24 Properties of Escherichia coli strains of serotype O6. Infection 1996 1.26
25 Reciprocal exchange of minor components of type 1 and F1C fimbriae results in hybrid organelles with changed receptor specificities. J Bacteriol 1994 1.23
26 Temperature-dependent expression of flagella in Legionella. J Gen Microbiol 1991 1.22
27 Characterization of the beta-lactamases of six species of Legionella. J Bacteriol 1982 1.20
28 Aggregation substance increases adherence and internalization, but not translocation, of Enterococcus faecalis through different intestinal epithelial cells in vitro. Infect Immun 2000 1.19
29 Renal tolerance and pharmacokinetics of vancomycin in rats. J Antimicrob Chemother 1984 1.17
30 O-antigen seroepidemiology of Klebsiella clinical isolates and implications for immunoprophylaxis of Klebsiella infections. Clin Diagn Lab Immunol 1997 1.17
31 Growth of Chlamydia pneumoniae induces cytokine production and expression of CD14 in a human monocytic cell line. Infect Immun 1996 1.17
32 Moxifloxacin prophylaxis in neutropenic patients. J Antimicrob Chemother 2006 1.16
33 [Epidemiology, diagnosis, antimicrobial therapy and management of community-acquired pneumonia and lower respiratory tract infections in adults. Guidelines of the Paul-Ehrlich-Society for Chemotherapy, the German Respiratory Society, the German Society for Infectiology and the Competence Network CAPNETZ Germany]. Pneumologie 2009 1.15
34 Hemagglutinating and adherence properties of Staphylococcus saprophyticus: epidemiology and virulence in experimental urinary tract infection of rats. FEMS Microbiol Immunol 1988 1.15
35 The structure of the O-specific chain of Legionella pneumophila serogroup 1 lipopolysaccharide. Eur J Biochem 1994 1.14
36 Molecular epidemiology of fluoroquinolone-resistant Escherichia coli bloodstream isolates from patients admitted to European cancer centers. Antimicrob Agents Chemother 1996 1.12
37 CAPNETZ-community-acquired pneumonia competence network. Infection 2004 1.11
38 [SARS--Severe Acute Respiratory syndrome]. Pneumologie 2003 1.09
39 De novo synthesis of Legionella pneumophila antigens during intracellular growth in phagocytic cells. Infect Immun 1996 1.06
40 Bacterial colonization and endotoxin contamination of intravenous infusion fluids. J Hosp Infect 1997 1.06
41 Colonization and infection with fluoroquinolone-resistant Escherichia coli among cancer patients: clonal analysis. Infection 1999 1.04
42 Cloning, genetic analysis, and nucleotide sequence of a determinant coding for a 19-kilodalton peptidoglycan-associated protein (Ppl) of Legionella pneumophila. Infect Immun 1991 1.04
43 Differential expression of interleukin-6, intracellular adhesion molecule 1, and major histocompatibility complex class II molecules in renal carcinoma cells stimulated with S fimbriae of uropathogenic Escherichia coli. Infect Immun 1993 1.04
44 Diagnosis of ornithosis by cell culture and polymerase chain reaction in a patient with chronic pneumonia. Clin Infect Dis 1995 0.99
45 Experimental studies on nephrotoxicity and pharmacokinetics of LY 146032 (daptomycin) in rats. J Antimicrob Chemother 1990 0.99
46 Protective effect of antilipopolysaccharide monoclonal antibody in experimental Klebsiella infection. Infect Immun 1997 0.99
47 Mycetoma due to Exophiala jeanselmei and Mycobacterium chelonae in a 73-year-old man with idiopathic CD4+ T lymphocytopenia. Mycoses 1996 0.99
48 Use of a receiver operating characteristic in the evaluation of two commercial enzyme immunoassays for detection of Helicobacter pylori infection. Eur J Clin Microbiol Infect Dis 1994 0.98
49 [S3-guideline on ambulant acquired pneumonia and deep airway infections]. Pneumologie 2005 0.97
50 Antibiotic-induced release of endotoxin: in-vitro comparison of meropenem and other antibiotics. J Antimicrob Chemother 1998 0.97
51 Sensitivity to sparfloxacin and other antibiotics, of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis strains isolated from adult patients with community-acquired lower respiratory tract infections: a European multicentre study. SPAR Study Group. Surveillance Programme of Antibiotic Resistance. J Antimicrob Chemother 1998 0.96
52 Bacterial lipopolysaccharide (LPS)-specific antibodies in commercial human immunoglobulin preparations: superior antibody content of an IgM-enriched product. Clin Exp Immunol 1998 0.96
53 Aggregation substance-mediated adherence of Enterococcus faecalis to immobilized extracellular matrix proteins. Microb Pathog 2001 0.95
54 Identification and characterization of a surface-associated protein (Ssp) of Staphylococcus saprophyticus. Infect Immun 1992 0.94
55 Survival of Chlamydia pneumoniae-infected Mono Mac 6 cells is dependent on NF-kappaB binding activity. Infect Immun 2001 0.94
56 Changes in Escherichia coli resistance patterns during and after antibiotic therapy: a longitudinal study among outpatients in Germany. Clin Microbiol Infect 2007 0.93
57 A fatal infection with Alternaria alternata and Aspergillus terreus in a child with agranulocytosis of unknown origin. Mycoses 1995 0.93
58 Evaluation of a competitive ELISA method for the determination of Klebsiella O antigens. J Med Microbiol 1996 0.93
59 Rapid and standardized detection of Chlamydia pneumoniae using LightCycler real-time fluorescence PCR. Eur J Clin Microbiol Infect Dis 2003 0.92
60 Identification of 27-oxo-octacosanoic acid and heptacosane-1,27-dioic acid in Legionella pneumophila. FEMS Microbiol Lett 1992 0.91
61 A randomized trial of roxithromycin in patients with acute leukemia and bone marrow transplant recipients receiving fluoroquinolone prophylaxis. Antimicrob Agents Chemother 1994 0.91
62 Impact of intravenous {beta}-lactam/macrolide versus {beta}-lactam monotherapy on mortality in hospitalized patients with community-acquired pneumonia. J Antimicrob Chemother 2009 0.90
63 Growth in serum-free medium improves isolation of Chlamydia pneumoniae. J Clin Microbiol 1993 0.89
64 Genetics of Escherichia coli uropathogenicity: analysis of the O6:K15:H31 isolate 536. Zentralbl Bakteriol 1992 0.89
65 Prevalence of resistance to clarithromycin and its clinical impact on the efficacy of Helicobacter pylori eradication. Scand J Gastroenterol 1999 0.89
66 Endocarditis caused by Bacillus circulans. Infection 1992 0.89
67 Legionella pneumophila infection in intratracheally inoculated T cell-depleted or -nondepleted A/J mice. J Immunol 1998 0.88
68 Age-dependent nephrotoxicity and the pharmacokinetics of gentamicin in rats. Eur J Pediatr 1980 0.87
69 Aggregation substance promotes colonic mucosal invasion of Enterococcus faecalis in an ex vivo model. J Surg Res 2000 0.87
70 Comparative in vitro activities of amoxicillin-clavulanate, ampicillin-sulbactam and piperacillin-tazobactam against strains of Escherichia coli and proteus mirabilis harbouring known beta-lactamases. Infection 1991 0.87
71 [Animal studies on antibacterial activity of 10 cephalosporins (author's transl)]. Zentralbl Bakteriol Orig A 1978 0.87
72 Adherence to and cytotoxicity of Escherichia coli for eucaryotic cell lines quantified by MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide). Zentralbl Bakteriol 1992 0.86
73 The microbiological efficacy of the combination of fosfomycin and vancomycin against clinically relevant staphylococci. Infection 1989 0.86
74 Interaction of fibronectin and aggregation substance promotes adherence of Enterococcus faecalis to human colon. Dig Dis Sci 2002 0.86
75 Characterization of the Legionella pneumophila gene ligA. Int J Med Microbiol 2000 0.86
76 Experimental investigations of cefuroxime in renal tolerance and therapeutic efficacy in pyelonephritis. Proc R Soc Med 1977 0.86
77 Subtyping of Legionella pneumophila serogroup 1 strains isolated in Germany using monoclonal antibodies. Zentralbl Bakteriol 1992 0.85
78 Influence of cloned tRNA genes from a uropathogenic Escherichia coli strain on adherence to primary human renal tubular epithelial cells and nephropathogenicity in rats. Infect Immun 1996 0.85
79 Influence of fosfomycin and tobramycin on vancomycin-induced nephrotoxicity. Infection 1985 0.84
80 In vitro activities of the lichen secondary metabolites vulpinic acid, (+)-usnic acid, and (-)-usnic acid against aerobic and anaerobic microorganisms. Antimicrob Agents Chemother 1995 0.84
81 A model of genital Chlamydia trachomatis infection using human xenografts in severe combined immunodeficiency mice. Infect Immun 1996 0.84
82 [Animal studies on nephrotoxicity of seven aminoglycoside antibiotics during long-term treatment (author's transl)]. Arzneimittelforschung 1979 0.84
83 Analysis of the humoral immune response to Chlamydia pneumoniae by immunoblotting and immunoprecipitation. Clin Diagn Lab Immunol 1999 0.84
84 [Animal experiments on the nephrotoxicity, pharmacokinetics and therapeutic efficacy of dibekacin]. Arzneimittelforschung 1981 0.83
85 Influence of R-plasmid mediated beta-lactamase production on the therapeutic efficacy of cefoxitin and cefamandole in experimental chemotherapy. J Antimicrob Chemother 1980 0.83
86 How deadly is seasonal influenza-associated pneumonia? The German Competence Network for Community-Acquired Pneumonia. Eur Respir J 2010 0.83
87 Experimental studies on the nephrotoxicity of amphotericin B in rats. J Antimicrob Chemother 1991 0.83
88 Fungaemia due to Candida pelliculosa in a case of acute pancreatitis. Mycoses 1993 0.82
89 Moxifloxacin monotherapy versus ß-lactam mono- or combination therapy in hospitalized patients with community-acquired pneumonia. J Infect 2011 0.82
90 Clearance of Chlamydia trachomatis-induced polyserositis in SCID mice requires both CD4+ and CD8+ cells. Med Microbiol Immunol 1998 0.82
91 Diagnostic value of bronchoalveolar lavage in patients with opportunistic and nonopportunistic bacterial pneumonia. Infection 1994 0.81
92 Guidelines of the Paul-Ehrlich-Society of Chemotherapy, the German Respiratory Diseases Society, the German Infectious Diseases Society and of the Competence Network CAPNETZ for the Management of Lower Respiratory Tract Infections and Community-acquired Pneumonia. Pneumologie 2010 0.80
93 Decontamination of a Mycoplasma-infected Chlamydia pneumoniae strain by pulmonary passage in SCID mice. Int J Med Microbiol 2000 0.80
94 Genomic structure and evolution of Legionella species. Curr Top Microbiol Immunol 2002 0.80
95 Enzyme immunoassay for detection of antibodies against isolated flagella of Legionella pneumophila. Eur J Clin Microbiol Infect Dis 1995 0.80
96 [Guidelines for the epidemiology, diagnosis, antimicrobial therapy and management of community-acquired pneumonia and lower respiratory tract infections in adults]. Dtsch Med Wochenschr 2010 0.79
97 Teicoplanin: 10 years of clinical experience. Infection 1995 0.79
98 [Bronchoscopic diagnosis of pneumonia with quantitative microbial count determination]. Dtsch Med Wochenschr 1990 0.79
99 Cleavage of tumor necrosis factor-alpha by Legionella exoprotease. APMIS 1993 0.79
100 A fatal infection due to Fusarium oxysporum in a child with Wilms' tumour. Case report and review of the literature. Mycoses 1993 0.79
101 [CAPNet--network of competence for community acquired pneumonia: structures and aims]. Pneumologie 2003 0.79
102 Standardization of a model of E. coli-pyelonephritis in rats. Zentralbl Bakteriol Mikrobiol Hyg A 1984 0.78
103 Legionella pneumophila invasion of MRC-5 cells induces tyrosine protein phosphorylation. Infect Immun 1999 0.78
104 Adhesion and internalization of E. coli strains expressing various pathogenicity determinants. Zentralbl Bakteriol 1993 0.78
105 Fosfomycin protects against tubulotoxicity induced by cis-diaminedichloroplatin and cyclosporin A in the rat. Klin Wochenschr 1987 0.78
106 Severe Chlamydia pneumoniae infection in patients with neutropenia: case reports and literature review. Clin Infect Dis 2000 0.78
107 The pharmacokinetics of cefixime in patients with renal insufficiency undergoing hemofiltration. J Chemother 1989 0.78
108 [Competence network "community acquired pneumonia" (CAPNETZ). A first interim report]. Internist (Berl) 2004 0.77
109 Antibiotic resistant fecal isolates of Enterococci among unselected patients outside the clinical sector: an epidemiological study from Southern Germany. Pharmacoepidemiol Drug Saf 2006 0.77
110 Identification and characterization of surface proteins from Staphylococcus saprophyticus. Zentralbl Bakteriol 1993 0.77
111 Animal studies on the reduction of aminoglycoside-induced nephrotoxicity by D-glucaro-1,5-lactam. Infection 1983 0.77
112 [Myeloperoxidase, lactoferrin and elastase in bronchoalveolar lavage and plasma in pneumonia]. Pneumologie 1992 0.77
113 Nocardial infection in a renal transplant recipient--a case report. Scand J Urol Nephrol Suppl 1985 0.75
114 Oral vaccination of rats with live avirulent Salmonella derivatives expressing adhesive fimbrial antigens of uropathogenic Escherichia coli. FEMS Microbiol Immunol 1989 0.75
115 Habekacin: nephrotoxicity, pharmacokinetics and prophylactic efficacy in rats. Arzneimittelforschung 1985 0.75
116 [Animal studies on ribostamycin (author's transl)]. Immun Infekt 1981 0.75
117 [Etiology of pathogen-induced changes between the toes in patients working under moist conditions]. Z Hautkr 1988 0.75
118 Antimicrobial agents in rats. II. Serum levels of oral cephalosporins. Arzneimittelforschung 1979 0.75
119 Interpretive criteria for susceptibility testing of coagulase-negative staphylococci with special reference to netilmicin. Infection 1997 0.75
120 [Bacteriologic studies of the amniotic fluid following amniocentesis]. Z Geburtshilfe Perinatol 1987 0.75
121 [Fosfomycin: animal experiments on nephrotoxicity, pharmacokinetics and therapeutic efficacy (author's transl)]. Immun Infekt 1980 0.75
122 [Ciprofloxacin and cefotaxim: pharmacokinetic and therapeutic effectiveness in E. coli pyelonephritis in rats]. Immun Infekt 1986 0.75
123 Comparative efficacy of different beta-lactam antibiotics and gentamicin in Klebsiella pneumoniae septicaemia in neutropenic mice. J Antimicrob Chemother 1986 0.75
124 Endocarditis caused by an unidentified gram-positive coccus. Eur J Clin Microbiol Infect Dis 1991 0.75
125 Bactericidal activity and induction of cell volume alterations of cephalosporins in Escherichia coli. Chemotherapy 1985 0.75
126 Adhesion of Staphylococcus saprophyticus to renal tubular epithelial cells is mediated by an N-acetyl-galactosamine-specific structure. Zentralbl Bakteriol 1991 0.75
127 The therapeutic response of cephalosporin-treated E. coli pyelonephritis of the rat, in relation to variations of the infection model. Zentralbl Bakteriol Mikrobiol Hyg A 1985 0.75
128 Influence of hemodilution on cefuroxime levels and bacterial contamination of intra- and postoperative processed wound blood during hip replacement. Beitr Infusionsther Transfusionsmed 1996 0.75
129 Analysis of cephalosporin-induced changes in the volume distribution of Escherichia coli cultures by an electronic counter-channelanalyser. Zentralbl Bakteriol Mikrobiol Hyg A 1984 0.75
130 [Prophylaxis and therapy of bronchial infections. Recommendations of the German Airway League of the German Pulmonology Association]. Med Klin (Munich) 1997 0.75
131 [Antibacterial in-vitro activity of pipemidic acid and nalidixic acid (author's transl)]. Dtsch Med Wochenschr 1979 0.75
132 [Multifocal nodular pneumonia following kidney transplantation (nocardiosis)]. Internist (Berl) 1983 0.75
133 [Scope and limitations of risk-adjusted evaluation of lethality in community-acquired pneumonia using data collected according to section 21 of the German Hospital Reimbursement Law (Krankenhaus-Entgeltgesetz, KHEntG)]. Pneumologie 2008 0.75
134 Antimicrobial agents in rats. I. Serum levels of parenteral cephalosporins. Arzneimittelforschung 1979 0.75
135 Investigations on the effectiveness of cefazedone in experimental E. coli pyelonephritis. Arzneimittelforschung 1979 0.75
136 Ceftazidime, ceftizoxime, cefotaxime and HR 221 in experimental chronic Escherichia coli pyelonephritis in rats. Infection 1983 0.75
137 [Prevention and therapy of bronchial infections. Recommendations of the German Respiratory League of the German Society of Pneumology]. Pneumologie 1998 0.75
138 [Netilmicin and tobramycin: comparative evaluation of pharmacokinetics, nephrotoxicity, and therapeutic efficacy in animal studies (author's transl)]. Arzneimittelforschung 1979 0.75
139 Is Escherichia coli invading tubuloepithelial cells? Zentralbl Bakteriol 1992 0.75
140 Idiopathic CD4+ T lymphocytopenia presenting as mycetoma in a patient with a mutation in the cystic fibrosis transmembrane regulator gene. Arch Dermatol 1996 0.75
141 [The diagnostic value of bronchoalveolar lavage in opportunistic pneumonia following kidney transplantation]. Pneumologie 1990 0.75
142 Purification and characterisation of elastase from Staphylococcus epidermidis. J Med Microbiol 1992 0.75
143 [Diagnosis and therapy of chlamydia infections]. Dtsch Med Wochenschr 1997 0.75
144 [Fatal Yersinia infection after intraoperative transfusion]. Anasthesiol Intensivmed Notfallmed Schmerzther 1996 0.75
145 Renal tolerance of imipenem/cilastatin and other beta-lactam antibiotics in rats. Infection 1985 0.75
146 [Chemotherapy with fosfomycin, cefoxitin, and cefotaxime in experimental E. coli-pleuropneumonia (author's transl)]. Immun Infekt 1981 0.75
147 Relationship between the bactericidal and bacteriolytic activity of cephalosporins and changes in the cell volumes of Escherichia coli cultures. Infection 1986 0.75
148 Biology and clinical significance of chlamydiae. Contrib Microbiol 2001 0.75
149 Prevalence and determinants of nasal colonization with antibiotic-resistant Staphylococcus aureus among unselected patients attending general practitioners in Germany. Epidemiol Infect 2004 0.75
150 [Bacteriologic studies in premature rupture of fetal membranes and correlation with the clinical aspects of chorioamnionitis and the amnion infection syndrome]. Zentralbl Gynakol 1987 0.75
151 [Correlation between nephrotoxic potential and renal accumulation of aminoglycosides]. Verh Dtsch Ges Inn Med 1978 0.75
152 [Interobserver agreement in the assessment of pulmonary infiltrates on chest radiography in community-acquired pneumonia]. Rofo 2007 0.75
153 Different mechanisms of TEM-1 and Oxa-1 mediated resistance to piperacillin in E. coli. Zentralbl Bakteriol Mikrobiol Hyg A 1984 0.75
154 [Experimental studies of the nephroprotective effect of fosfomycin]. Wien Med Wochenschr 1987 0.75
155 Comparative efficacy of ciprofloxacin, ceftazidime and gentamicin, given alone or in combination, in a model of experimental septicemia due to Klebsiella pneumoniae in neutropenic mice. Infection 1988 0.75
156 [Comparative susceptibility testing to sulfamethoxazole and trimethoprim by agar diffusion test on different media (author's transl)]. Immun Infekt 1978 0.75